Perrigo's quarterly profit came from selling a business, not from operations
Perrigo booked $74.50 M of net income this quarter, but its core business barely showed up. Operating income was just $23.50 M, while selling the Dermacosmetics business produced a pre-tax gain of $129.50 M, recorded in other income. Strip that gain out and pre-tax income of $105.40 M becomes a loss of $24.10 M. Operating income did not even cover the $38.40 M of net interest expense. Management's own discussion shows operating income down 48.4% from a year earlier. The black ink came from a sale, and a business can only be sold once.
Why did the core weaken? Gross margin fell to 30.7% from 34.4%. Management blames "lower net sales volumes, primarily within our Self Care reporting segment", plus under-absorption, meaning factories spreading fixed costs over fewer units. Self Care sales fell 3.7%, hurt by a weaker cough and cold season and lower retailer inventories. Specialty Care segment profit dropped $18.50 M. Cost cuts helped, with operating expenses down $27.0 million, mainly administration under the Operational Enhancement Program. Yet restructuring still cost $14.40 M this quarter, and in the first quarter Perrigo wrote off $330.80 M of goodwill, the premium once paid for acquired businesses.
For shareholders, the $0.53 of diluted earnings per share rests on a gain that will not recur. The sale did buy breathing room: Perrigo used the proceeds to repay $335.0 million on its revolving credit facility. Its lenders hold a covenant requiring an interest coverage ratio of at least 3.00 to 1.00 at each quarter-end, measured under the credit agreement's own terms. Watch whether Self Care volumes recover and whether cost savings reach gross margin. Without another business to sell, can operating income alone carry the interest bill?

